InvestorsHub Logo
Followers 23
Posts 2120
Boards Moderated 0
Alias Born 06/21/2015

Re: A_Good_Day_2 post# 128356

Saturday, 11/04/2017 11:25:01 AM

Saturday, November 04, 2017 11:25:01 AM

Post# of 461255
Follow the link

Clinical Pharmacokinetics and Pharmacodynamics Characterization of ANAVEX2-73 for Designing a Phase 2/3 Study in Mild-to-Moderate Alzheimer's Disease
Mohammad Afshar, MD, PhD Ariana Pharma, Paris, France

http://www.ctad-alzheimer.com/presentations
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News